Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive analysis of RAS-effector interactions reveals interaction hotspots and new binding partners
Soheila Rezaei Adariani, Neda S. Kazemein Jasemi, Farhad Bazgir, et al.
Journal of Biological Chemistry (2021) Vol. 296, pp. 100626-100626
Open Access | Times Cited: 22

Showing 22 citing articles:

Anticancer drug resistance: An update and perspective
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Drug Resistance Updates (2021) Vol. 59, pp. 100796-100796
Open Access | Times Cited: 251
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
Sílvia Casacuberta‐Serra, Íñigo González-Larreategui, Daniel Capitán-Leo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Functional and structural insights into RAS effector proteins
Alessandro M. Mozzarelli, Dhirendra K. Simanshu, Pau Castel
Molecular Cell (2024) Vol. 84, Iss. 15, pp. 2807-2821
Closed Access | Times Cited: 4
B-AP15 inhibited colon cancer cell proliferation by decreasing CDK6, Cyclin A, Cyclin E, c-Myc, and VEGF gene expression
Thanet Sophonnithiprasert, Sasiwan Konjanthet, Nattanicha Narinnork, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Complex interplay between RAS GTPases and RASSF effectors regulates subcellular localization of YAP
Swati Singh, Gabriela Bernal Astrain, Ana Maria Hincapie, et al.
EMBO Reports (2024) Vol. 25, Iss. 8, pp. 3574-3600
Closed Access | Times Cited: 3
SHANK3 depletion leads to ERK signalling overdose and cell death in KRAS-mutant cancers
Johanna Lilja, Jasmin Kaivola, James R. W. Conway, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Functional diversity in the RAS subfamily of small GTPases
Gabriela Bernal Astrain, Maya Nikolova, Matthew J. Smith
Biochemical Society Transactions (2022) Vol. 50, Iss. 2, pp. 921-933
Closed Access | Times Cited: 14
KRAS-driven Tumorigenesis and KRAS-driven Therapy in Pancreatic Adenocarcinoma
Minh T. Than, Mark H. O’Hara, Ben Z. Stanger, et al.
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 10, pp. 1378-1388
Closed Access | Times Cited: 2
Analysis of KRAS–Ligand Interaction Modes and Flexibilities Reveals the Binding Characteristics
Zheng Zhao, Niraja Bohidar, Philip E. Bourne
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 4, pp. 1362-1370
Closed Access | Times Cited: 6
Analysis of context-specific KRAS–effector (sub)complexes in Caco-2 cells
Camille Ternet, Philipp Junk, Thomas Sevrin, et al.
Life Science Alliance (2023) Vol. 6, Iss. 5, pp. e202201670-e202201670
Open Access | Times Cited: 6
GAP positions catalytic H-Ras residue Q61 for GTP hydrolysis in molecular dynamics simulations, complicating chemical rescue of Ras deactivation
Lara A. Patel, Timothy J. Waybright, Andrew Stephen, et al.
Computational Biology and Chemistry (2023) Vol. 104, pp. 107835-107835
Closed Access | Times Cited: 2
Structure-based prediction of Ras-effector binding affinities and design of “branchegetic” interface mutations
Philipp Junk, Christina Kiel
Structure (2023) Vol. 31, Iss. 7, pp. 870-883.e5
Open Access | Times Cited: 2
Far-reaching effects of tyrosine64 phosphorylation on Ras revealed with BeF3– complexes
Patrick Baumann, Yi Jin
Communications Chemistry (2024) Vol. 7, Iss. 1
Open Access
Translational study on the role of genetic and prenatal risk factors in neurodevelopmental psychiatric disorders
Anna Yotova
(2024)
Open Access
Prediction of hot spots in protein-protein interaction by Nine-Pipeline & Ensemble Learning strategy
Jing Hu, Zonghao Li, Xiaolong Zhang, et al.
2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) (2021), pp. 2223-2230
Closed Access | Times Cited: 2
Analysis of context-specific KRAS-effectors (sub)complexes in Caco-2 cells
Camille Ternet, Philipp Junk, Thomas Sevrin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Systematic Analysis of KRAS-ligand Interaction Modes and Flexibilities Reveals the Binding Characteristics
Zheng Zhao, Niraja Bohidar, Philip E. Bourne
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Connecting developmental defects and evolutionary findings
Moyra Smith
Elsevier eBooks (2023), pp. 327-357
Closed Access
Editorial: Identifying the isoform-specific roles of RAS paralogs in health and disease
Saeideh Nakhaei‐Rad, Anna Fejtová
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access
Phylogenetic analysis and interactomics study unveil gene co-optive evolution of LysR-type transcription regulators across non-pathogenic, opportunistic, and pathogenic mycobacteria
Ekta Tyagi, Nirjara Singhvi, Chetkar Chandra Keshavam, et al.
3 Biotech (2023) Vol. 13, Iss. 6
Closed Access
Far-reaching Effects of Tyrosine64 Phosphorylation on Ras Revealed with BeF3– Complexes
Yi Jin, Patrick Baumann
Research Square (Research Square) (2023)
Open Access
Structure-based prediction of Ras-effector binding affinities and design of ‘branchegetic’ interface mutations
Philipp Junk, Christina Kiel
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top